Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alto Pharmacy
AddedFeb 13, 2024
UpdatedJun 18, 2026
Alto Pharmacy

Alto Pharmacy

Acquired

Alto, America's leading digital pharmacy, combines expert care and technology for convenient, affordable medication management.

HQ
San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
News

Founded in 2015, Alto Pharmacy is a leading digital pharmacy in the United States, aiming to transform the $500 billion pharmacy industry. The company's core mission is to enhance the role of pharmacists in healthcare by leveraging technology to provide a more convenient and affordable medication management experience. Alto offers services such as prescription fulfillment, medication delivery, and a mobile app for seamless management. The company focuses on improving patient outcomes and accessibility in the pharmaceutical market.

Notable affiliated individuals include co-founders Jamie Karraker and Matt Gamache-Asselin. Alto has attracted significant investment from prominent venture capital firms like SoftBank Vision Fund and Greenoaks Capital. Key achievements include fulfilling over three million prescriptions and expanding operations to twelve markets. Alto's innovative approach has significantly impacted the digital pharmacy landscape, making medication management more efficient and patient-centric.

Alto Pharmacy - Similar Companies

Truepill logo

Truepill

NimbleRx logo

NimbleRx

nimblerx.com

GeniusRx logo

GeniusRx

geniusrx.com

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

RxLive logo

RxLive

rxlive.com

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

Aspen RxHealth logo

Aspen RxHealth

aspenrxhealth.com

Capital Rx logo

Capital Rx

cap-rx.com

SmithRx logo

SmithRx

smithrx.com

ActualMeds logo

ActualMeds

actualmeds.com

PipelineRx logo

PipelineRx

pipelinerx.com

RxAnte logo

RxAnte

rxante.com

DiRx logo

DiRx

dirxhealth.com

Pills2Me logo

Pills2Me

pills2me.com

SmartScripts logo

SmartScripts

smartscripts.com

Alto Pharmacy - Quick Facts

Who are Alto Pharmacy's competitors?

Companies similar to Alto Pharmacy include Truepill, NimbleRx, GeniusRx and ScriptAssist Pharmacy.

When was Alto Pharmacy founded?

Alto Pharmacy was founded in 2015.

Where is Alto Pharmacy's headquarters located?

Alto Pharmacy's headquarters is located in San Francisco, CA, US.

When was Alto Pharmacy's last funding round?

Alto Pharmacy's most recent funding round was for $120M (USD) in September 2023.

How much has Alto Pharmacy raised to-date?

As of Sep 25, 2023, Alto Pharmacy has raised a total of $680M (USD).

Alto Pharmacy - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
  • Transactional
Customer
  • Consumers
Main Product
  • Medication Management
  • Pharmacy
Tags
  • Healthtech
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 440000Retail Trade
  • 620000Health Care and Social Assistance
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores